|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Product revenue, net | |||||
| License, collaboration and other revenue | |||||
| Total revenues | |||||
| Cost of goods sold: | |||||
| Cost of product and other revenue | |||||
| Amortization of intangible asset | |||||
| Total cost of goods sold | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| License | |||||
| Restructuring | |||||
| Total operating expenses | |||||
| Income (loss) from operations | |||||
| Other income (expense): | |||||
| Interest expense | |||||
| Other income | |||||
| Change in fair value of warrant liability | |||||
| Loss on extinguishment of debt | |||||
| Loss on termination of lease | |||||
| Loss before income taxes | |||||
| Income tax expense | |||||
| Net loss | |||||
| Comprehensive loss | |||||
| Net loss per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average number of common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...